RESUMO
BACKGROUND: Electronic health record (EHR) based chronic kidney disease (CKD) registries are central to population health strategies to improve CKD care. In 2015, Partners Healthcare System (PHS), encompassing multiple academic and community hospitals and outpatient care facilities in Massachusetts, developed an EHR-based CKD registry to identify opportunities for quality improvement, defined as improvement on both process measures and outcomes measures associated with clinical care. METHODS: Patients are included in the registry based on the following criteria: 1) two estimated glomerular filtration rate (eGFR) results < 60 ml/min/1.73m2 separated by 90 days, including the most recent eGFR being < 60 ml/min/1.73m2; or 2) the most recent two urine protein values > 300 mg protein/g creatinine on either urine total protein/creatinine ratio or urine albumin/creatinine ratio; or 3) an EHR problem list diagnosis of end stage renal disease (ESRD). The registry categorizes patients by CKD stage and includes rates of annual testing for eGFR and proteinuria, blood pressure control, use of angiotensin converting enzyme inhibitors (ACE-Is) or angiotensin receptor blockers (ARBs), nephrotoxic medication use, hepatitis B virus (HBV) immunization, vascular access placement, transplant status, CKD progression risk; number of outpatient nephrology visits, and hospitalizations. RESULTS: The CKD registry includes 60,503 patients and has revealed several opportunities for care improvement including 1) annual proteinuria testing performed for 17% (stage 3) and 31% (stage 4) of patients; 2) ACE-I/ARB used in 41% (stage 3) and 46% (stage 4) of patients; 3) nephrotoxic medications used among 23% of stage 4 patients; and 4) 89% of stage 4 patients lack HBV immunity. For advanced CKD patients there are opportunities to improve vascular access placement, transplant referrals and outpatient nephrology contact. CONCLUSIONS: A CKD registry can identify modifiable care gaps across the spectrum of CKD care and enable population health strategy implementation. No linkage to Social Security Death Master File or US Renal Data System (USRDS) databases limits our ability to track mortality and progression to ESRD.
Assuntos
Registros Eletrônicos de Saúde/organização & administração , Administração dos Cuidados ao Paciente , Sistema de Registros/estatística & dados numéricos , Insuficiência Renal Crônica , Idoso , Prestação Integrada de Cuidados de Saúde/métodos , Prestação Integrada de Cuidados de Saúde/normas , Feminino , Necessidades e Demandas de Serviços de Saúde , Humanos , Testes de Função Renal/métodos , Testes de Função Renal/estatística & dados numéricos , Masculino , Massachusetts/epidemiologia , Pessoa de Meia-Idade , Gravidade do Paciente , Administração dos Cuidados ao Paciente/métodos , Administração dos Cuidados ao Paciente/estatística & dados numéricos , Gestão da Saúde da População , Melhoria de Qualidade/organização & administração , Insuficiência Renal Crônica/epidemiologia , Insuficiência Renal Crônica/terapiaRESUMO
Specialty care contributes significantly to total medical expenditures, for which accountable care organizations (ACOs) are responsible. ACOs have sought to replace costly in-person visits with lower-cost alternatives such as virtual visits (videoconferencing with physicians). In fee-for-service environments, virtual visits appear to add to in-person visits instead of replacing them. While this may be less of a problem within ACOs, whether virtual visits reduce in-person visits in an ACO is not known. Using data from over 35,000 patients in the period 2014-17 within a Massachusetts-based ACO, we found that the use of virtual visits reduced in-person visits by 33 percent but increased total visits (virtual plus in-person visits) by 80 percent over 1.5 years. While the use of virtual visits reduced in-person visits soon after registering with the program, the effect did not endure beyond a year. Whether and how virtual visits can substitute for in-person care in the long term are open questions.
Assuntos
Organizações de Assistência Responsáveis/economia , Gastos em Saúde/estatística & dados numéricos , Medicina/métodos , Consulta Remota/estatística & dados numéricos , Redução de Custos/estatística & dados numéricos , Humanos , Massachusetts , Medicare , Visita a Consultório Médico/estatística & dados numéricos , Médicos , Estados UnidosAssuntos
Certificação/estatística & dados numéricos , Médicos/normas , Reembolso de Incentivo/estatística & dados numéricos , Adulto , Idoso , Certificação/métodos , Competência Clínica/normas , Feminino , Gastos em Saúde/estatística & dados numéricos , Humanos , Masculino , Pessoa de Meia-Idade , Qualidade da Assistência à Saúde/economia , Qualidade da Assistência à Saúde/normas , Qualidade da Assistência à Saúde/tendênciasRESUMO
Since its passage in 2010, the Affordable Care Act has led to the creation of numerous accountable care organizations that face the challenge of transforming the traditional care delivery model to provide more patient-centered, high-quality, and low-cost care. Complex patients, including those with chronic kidney disease (CKD), present the most challenges and opportunities. CKD is a condition with significant morbidity, mortality, and cost and thought to be partly secondary to known gaps in care delivery. Successful population management for CKD requires consideration of the needs of patients at all phases of the disease. In this article, we offer a comprehensive framework for a population-based approach to CKD and examples of programs we are implementing in each area. These initiatives include the development and implementation of an electronic nephrology consult (e-consult) platform, CKD quality metrics, CKD registry, CKD collaborative care agreement, multidisciplinary care clinic for advanced CKD, end-stage renal disease care coordinator program, shared decision-making tools for renal replacement, CKD education videos, and a tablet-based CKD patient-reported outcome measures tool.
Assuntos
Organizações de Assistência Responsáveis , Patient Protection and Affordable Care Act , Insuficiência Renal Crônica/terapia , Progressão da Doença , Humanos , Falência Renal Crônica/terapia , Melhoria de Qualidade , Diálise Renal , Insuficiência Renal Crônica/complicaçõesRESUMO
Hospital readmissions are common and costly and, in some cases, may be related to problems with care processes. We sought to reduce readmissions after percutaneous coronary intervention (PCI) in a large tertiary care facility through programs to target vulnerabilities predischarge, after discharge, and during re-presentation to the emergency department. During initial hospitalization, we assessed patients' readmission risk with a validated risk score and used a discharge checklist to ensure access to appropriate medications and close follow-up for high-risk patients. We also developed patient education videos about chest discomfort and heart failure. After discharge, we established a new follow-up clinic with cardiology fellows. A computerized system was developed to automatically notify cardiologists when patients presented to the emergency department within 30 days of PCI to enhance patient access to cardiology care in the emergency department. Early cardiologist assessment and assistance with triage was encouraged, and the emergency department used a risk stratification algorithm derived from a local database of patients to triage patients presenting with chest discomfort after PCI. We tracked the number of patients readmitted after PCI to our hospital. With our interventions, from 2011 to 2015, the index hospital readmission rate has declined from 9.6% to 5.3%. This program could provide tangible structural changes that can be implemented in other healthcare centers, both reducing the cost of care and improving the quality of care for patients with PCI.
Assuntos
Serviço Hospitalar de Cardiologia/organização & administração , Prestação Integrada de Cuidados de Saúde/organização & administração , Alta do Paciente , Readmissão do Paciente , Intervenção Coronária Percutânea/efeitos adversos , Algoritmos , Lista de Checagem , Serviço Hospitalar de Emergência/organização & administração , Feminino , Acessibilidade aos Serviços de Saúde/organização & administração , Humanos , Masculino , Pessoa de Meia-Idade , Educação de Pacientes como Assunto , Avaliação de Programas e Projetos de Saúde , Melhoria de Qualidade , Indicadores de Qualidade em Assistência à Saúde , Medição de Risco , Fatores de Risco , Autocuidado , Centros de Atenção Terciária , Fatores de Tempo , Resultado do Tratamento , TriagemRESUMO
New healthcare delivery models, including accountable care organizations (ACOs) and patient-centered medical homes, emphasize a more robust role for primary care. However, it is less clear how the roles and responsibilities of subspecialists should change as we enter a new paradigm of alternative payment models. Health systems seeking to better manage population health and control costs will need a clearer understanding of how best to incorporate subspecialty practitioners: What is a subspecialist's role? How does it vary by subspecialty? How should they be compensated? We argue that subspecialist compensation in ACOs and other new care delivery models should recognize the range of ways in which specialists can provide value to patients across a population-which varies depending on the provider's role in a patient's care. Only by more thoughtfully engaging, equipping, and compensating subspecialty practitioners can we achieve reform's central goal of better population health at a lower cost.
Assuntos
Organizações de Assistência Responsáveis/organização & administração , Atenção à Saúde/organização & administração , Programas de Assistência Gerenciada/organização & administração , Atenção Primária à Saúde/organização & administração , Feminino , Humanos , Masculino , Assistência Centrada no Paciente/organização & administração , Saúde da População , Padrões de Prática Médica , Especialização , Estados UnidosAssuntos
Doenças Cardiovasculares , Redução de Custos , Consulta Remota , Atitude do Pessoal de Saúde , Doenças Cardiovasculares/diagnóstico , Doenças Cardiovasculares/economia , Doenças Cardiovasculares/terapia , Atenção à Saúde/métodos , Custos de Cuidados de Saúde , Pesquisas sobre Atenção à Saúde , Humanos , Preferência do Paciente , Projetos Piloto , Consulta Remota/métodos , Consulta Remota/organização & administraçãoRESUMO
US health-care costs are growing at an alarming rate. "Value-based" payment models that hold providers accountable for outcomes and costs of care are becoming more prevalent. In these arrangements, provider groups will be accountable for the costs of lab tests, many of which have traditionally been revenue-generating. "Stewardship" programs aimed at newer, high-cost specialized tests, decision support on more routine tests, variation reporting, and incentives are familiar tactics that will need to be deployed in this new context.